ArticleMedChemComm2012

A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.

Jonathan F Arambula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.